Which medication is more effective as a first-line agent for status epilepticus, midazolam or lorazepam?

Patricia Adam, Nicole Kilby

Family Medicine and Community Health (Twin Cities)

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	E16-E17
Journal	Evidence-Based Practice
Volume	21
Issue number	6
State	Published - Jun 2018

OpenUrl availability

Other files and links

Cite this

@article{d87d2ccb65634a1098792bc201c71462,

title = "Which medication is more effective as a first-line agent for status epilepticus, midazolam or lorazepam?",

author = "Patricia Adam and Nicole Kilby",

year = "2018",

month = jun,

language = "English (US)",

volume = "21",

pages = "E16--E17",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Dowden Health Media,Inc",

number = "6",

}

TY - JOUR

T1 - Which medication is more effective as a first-line agent for status epilepticus, midazolam or lorazepam?

AU - Adam, Patricia

AU - Kilby, Nicole

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85050927905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050927905&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:85050927905

SN - 1095-4120

VL - 21

SP - E16-E17

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 6

ER -